A Demographic Study of Chronic Bronchitis: An Observational Study
Background: Chronic bronchitis is a global public health problem affecting those over the age of 40, and it will continue to be a challenge in the future. It is a leading cause of chronic morbidity and mortality around the world.
Objective: The purpose of this study is to determine the demographic status of chronic bronchitis patients.
Materials and Methods: It is an open-label clinical study conducted on 50 diagnosed patients who visited the Moalejat, Ajmal Khan Tibbiya College and Hospital, Aligarh Muslim University, selected for further inquiry regarding age, sex, occupation, temperament, seasonal variations, etiological factors.
Results: In the present study, among the patients selected for chronic bronchitis,it was observed that maximum participants 17(34.0%) belonged to the age group of 60-65 years and patients were also evaluated based on the history of risk factors. Among various risk factors, cigarette smoking is a vital risk factor, accounting for 94% of patients in our study.
Conclusion: In conclusion, every tool should be leveraged to raise CB awareness and implement an effective COPD/CB early detection programme in our community.
How to cite this article:
Zehra A, Mannan A, Naseer M, Ahmad QZ. A Demographic Study of Chronic Bronchitis: An Observational Study. J Integ Comm Health. 2021;10(2):3-7.
Kim V, Criner JG. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(3)228-37. [Google Scholar]
Dale DC, Federman DC. ACP medicine. 3rd ed. WebMD; 2007.
Standard medical Unani terminology. CCRUM-Ministry of health and family welfare, Government of India, New Delhi; 2012. 205 p.
Sina I. Al-Qanoon-fil-Tibb (Urdu translation by Kantoori GH). Vol I. New Delhi: IdaraeKitabusShifa;Year not mentioned. 718-22.
Jurjani I. ZakheeraKhawarezam Shahi (Urdu translation by Hadi Hasan Khan). Vol 6. Lucknow: Munshi Nawal Kishore Publication; 2010. p. 264-71.
Khan A. Akseer Azam (Urdu translation by Kabiruddin). New Delhi:Idare kitab-us-shifa; 2011. p. 268-77.
World Health Organization [Internet]. WHO chronic respiratory diseases; [cited 2021 Mar 30]. Available from: https://www.who.int/health-topics/chronicrespiratory-diseases#tab=tab_1
Manthappa M. Manipal prep manual of medicine. 2nd ed. CBS Publisher & Distributors Pvt Ltd; 2016. p. 112-15.
Munjal YP, Sharma SK, Agarwal MD, Gupta MD, Kamath MD. API textbook of medicine.11th ed. Jaypee Brothers Medical Publishers (P) Ltd; 2019. p. 1298-308.
Warrell DA, Firth JD, Cox TM. Oxford textbook of medicine. 5th ed. Oxford University Press; 2010.
Golwalla AF, Golwalla SA. Medicine for students. A reference book for the Family Physician. 22nd ed.Mumbai: National Book Depot; 2008. p. 120-23.
Walker BR, Colledge NR, Ralston SH, Penman ID. Davidson’s principle and practice of medicine. 22nd ed. Elsevier; 2014. p. 673-8.
Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D’Souza GA, Gupta D, Katiyar SK, Kumar R, Shah B, Vijayan VK; Asthma Epidemiology Study Group. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci. Jan-Mar 2006;48(1):23-9. [PubMed] [Google Scholar]
Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, Hersh CP, Stinson D, Silverman EK, Criner GJ; COPD Gene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPD Gene Study. Chest. 2011 Sep;140(3):626-33. [PubMed] [Google Scholar]
David MM, Buist AS. Global burden of COPD: risk factors, prevalence and future trends. Lancet. 2007 Sep;370(9589):765-73. [PubMed] [Google Scholar]
Mejza F, Gnatiuc L, Buist AS, Vollmer WM, Lamprecht B, Obaseki DO, Nastalek P, Nizankowska-Mogilnicka E, Burney PGJ; BOLD collaborators; BOLD study collaborators. Prevalence and burden of chronic bronchitis symptoms: result from BOLD study. Eur Respir J. 2017 Nov;50(5):1700621. [PubMed] [Google Scholar]
Rabe KF, Fabbri LM, Vogelmeier C, Kögler H, Schmidt H, Beeh KM, Glaab T.Seasonal distribution of COPD exacerbation in the prevention of exacerbation with tiotropium in COPD trial. Chest. 2013 Mar;143(3):711-9. [PubMed] [Google Scholar]